Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Agoracoms censorship is a red flag!

It's all relative. For the sake of example, here's a link to TMTA's press releases.

http://investor.transmeta.com/releas...

Their press releases consist primarily of license agreements, new officers, quarterly/annual reports, and other significant events, a total of twenty since March 2007. When you count PTSC releases similar to those of TMTA, PTSC has issued roughly twice the releases over the same timeframe. My point here is that the magnitude and type of information we are getting from the company is not outside the norm.

My impression is that some are desiring more details about business activities than what is typically provided to shareholders by a public company. It is more commonplace for shareholders find out about significant events after they are complete. Nobody on this board has any idea what's going on behind the scenes right now, but I presume that Turley is actively pursuing business opportunities in accordance with what he has indicated in his shareholder letters. Eventually, we will find out whether he is a man of his word, and whether he has what it takes to lead PTSC to the next level. Until then, I personally am taking this opportunity to learn what patience in the face of adversity is all about. Four years and counting.

Have a great weekend!

Share
New Message
Please login to post a reply